Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease
Clinical trial NCT00130260 · TERMINATED
Trial details
- NCT number
- NCT00130260
- Sponsor
- Nabi Biopharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2005-12-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.